This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at email@example.com or call 800-767-3771 ext. 9339.
• Joy Global Inc. (NASDAQ:JOYG) posted Q2 EPS of $1.52, higher than the Zacks Consensus Estimate of $1.35 per share. Revenue for the quarter grew 19% to $1.06 billion, beating the Zacks Consensus Estimate of $1.038 billion
• According to reports, Ford Motor Co (NYSE:F) is planning to invest around $100 million in robotic laser technology which will reduce wind noise inside vehicles
• Baird upgraded shares of Affymetrix, Inc. (NASDAQ: AFFX) to "Outperform" rating from "Neutral" rating, raising the target price to $11 from $6
• Shares of Johnson & Johnson (NYSE:JNJ) were upgraded by analysts of First Global to "Moderate Outperform" rating from "Market Perform" rating
• Analysts at BofA Merrill Lynch upgraded DeVry Inc. (NYSE:DV) to "Buy" rating from "Neutral" rating with a target price of $68 on the stock
• Analysts at Standpoint Research upgraded shares of Microsoft Corp (NASDAQ:MSFT) to "Buy" rating from "Hold" rating with a target price of $29 on the stock
• EnergySolutions, Inc. (NYSE:ES) was downgraded by Wedbush to "Neutral" rating from "Outperform" rating, cutting its target price to $5.50 from $7.50
• Shares of Sempra Energy (NYSE:SRE) were downgraded by JPMorgan (NYSE:JPM) to "Neutral" rating from "Overweight" rating, reducing the target price to $58 from $63
• Shares of AstraZeneca (NYSE:AZN) were downgraded by Jefferies to "Underperform" rating from "Hold" rating
• Goldman Sachs (NYSE:GS) initiated coverage on shares of Dendreon Corp (NASDAQ:DNDN) with a "Buy" rating and a target price of $50 per share
• Leerink Swann initiated coverage on shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) with an "Outperform" rating
• Merriman Curhan Ford initiated coverage on shares of RealD (NYSE:RLD) with a "Buy" and a target price range of $29 to $35
Please login to Zacks.com or register to post a comment.